US may curb China's edge in clinical trials

China leads early clinical trials due to speed and lower costs.

Published 1j4 sources✓ ConfirmedImportantupdated 1j

≈ 15sSpeed

The fact

US lawmakers and the FDA are considering measures to curb this advantage.

Stricter regulations could slow Chinese pharmaceutical innovation.

4 sources — click a link to read an article on the topic:

Explore this topic

Auto-synthesis from 4 media sources · identified on September 23, 2026